StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories abbott India — Domestic Institutional Investors (DIIs) Shareholding (%) (%)

Abbott India Limited Shareholding Pattern Filings

QuarterlyAnnual
Latest, Q3 2026
9.0%
Period ended Sep 30, 2026
Change on a year earlier
-0.1 pts
9.1% in Q3 2025
History
12 quarters
Since Q4 2023
Sources
1
Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in)

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAbbott India — Domestic Institutional Investors (DIIs) Shareholding (%) (%)Year on yearSource
Q3 2026Sep 30, 20269.0%-0.1 ptsAbbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q2 2026Jun 30, 20268.8%-0.4 ptsAbbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q1 2026Mar 31, 20268.9%+0.0 ptsAbbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q4 2025Dec 31, 20259.0%-0.0 ptsAbbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q3 2025Sep 30, 20259.1%+0.1 ptsAbbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q2 2025Jun 30, 20259.2%+0.4 ptsAbbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q1 2025Mar 31, 20258.9%0.0 ptsAbbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q4 2024Dec 31, 20249.0%+0.3 ptsAbbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q3 2024Sep 30, 20249.0%–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q2 2024Jun 30, 20248.8%–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q1 2024Mar 31, 20248.9%–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗
Q4 2023Dec 31, 20238.7%–Abbott India Limited (NSE: ABBOTINDIA) Consolidated Financial & Shareholding Filings (Screener.in) ↗

Cite this data

StockData. (2026). Abbott Laboratories Abbott India — Domestic Institutional Investors (DIIs) Shareholding (%) (%), quarterly Q4 2023–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ind-sh-dii

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.